Literature DB >> 15014971

Molecular cloning and functional analysis of porcine SULT1A1 gene and its variant: a single mutation SULT1A1 causes a significant decrease in sulfation activity.

Zhihong Lin1, Yanping Lou, James E Squires.   

Abstract

The characterization of the SULT1A1 gene and its variants should have an important impact on the efforts to develop genetic markers to select for low skatole in pigs. Raising intact male pigs would have a significant economic impact on the pork industry; however, the presence of skatole (a major cause of boar taint) in meat from male pigs would be highly objectionable to consumers. It has been shown that the phase II metabolism of skatole metabolites by phenol sulfotransferase is related to the clearance of skatole in the liver. The aim of this study was to isolate and characterize the SULT1A1 gene from pig liver, examine its expression, identify genetic polymorphisms, and study how a genetic variation in this enzyme translates into interindividual variation in skatole levels. We show here that a substitution of A-->G at base 546 of SULT1A1 causes a significant decrease in its sulfation activity and thus may be at least partially responsible for a higher level of skatole in pigs. Our findings provide an important basis toward the goal of making it possible to predict the sulfation status in pigs and the development of genetic markers for low skatole.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15014971     DOI: 10.1007/s00335-002-2318-4

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  18 in total

1.  Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype.

Authors:  R B Raftogianis; T C Wood; D M Otterness; J A Van Loon; R M Weinshilboum
Journal:  Biochem Biophys Res Commun       Date:  1997-10-09       Impact factor: 3.575

2.  Isolation and characterization of a bovine gene encoding phenol sulfotransferase.

Authors:  T Henry; B Kliewer; R Palmatier; J S Ulphani; J D Beckmann
Journal:  Gene       Date:  1996-10-03       Impact factor: 3.688

3.  Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancer.

Authors:  D E Bamber; A A Fryer; R C Strange; J B Elder; M Deakin; R Rajagopal; A Fawole; R A Gilissen; F C Campbell; M W Coughtrie
Journal:  Pharmacogenetics       Date:  2001-11

4.  Enzymatic characterization and interspecies difference of phenol sulfotransferases, ST1A forms.

Authors:  W Honma; Y Kamiyama; K Yoshinari; H Sasano; M Shimada; K Nagata; Y Yamazoe
Journal:  Drug Metab Dispos       Date:  2001-03       Impact factor: 3.922

5.  Relationship between oxidation and conjugation metabolism of skatole in pig liver and concentrations of skatole in fat.

Authors:  J Babol; E J Squires; K Lundström
Journal:  J Anim Sci       Date:  1998-03       Impact factor: 3.159

6.  Human phenol sulfotransferase STP2 gene: molecular cloning, structural characterization, and chromosomal localization.

Authors:  C Her; R Raftogianis; R M Weinshilboum
Journal:  Genomics       Date:  1996-05-01       Impact factor: 5.736

7.  Cloning, structural organization, and chromosomal mapping of the human phenol sulfotransferase STP2 gene.

Authors:  A Gaedigk; B G Beatty; D M Grant
Journal:  Genomics       Date:  1997-03-01       Impact factor: 5.736

8.  Molecular biology of the human phenol sulfotransferase gene family.

Authors:  T P Dooley
Journal:  J Exp Zool       Date:  1998 Sep-Oct 1

9.  Functional characterization of two human sulphotransferase cDNAs that encode monoamine- and phenol-sulphating forms of phenol sulphotransferase: substrate kinetics, thermal-stability and inhibitor-sensitivity studies.

Authors:  M E Veronese; W Burgess; X Zhu; M E McManus
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

10.  Phase II in vitro metabolism of 3-methylindole metabolites in porcine liver.

Authors:  G J Diaz; E J Squires
Journal:  Xenobiotica       Date:  2003-05       Impact factor: 1.908

View more
  7 in total

1.  A novel polymorphism in the 5' untranslated region of the porcine cytochrome b5 (CYB5) gene is associated with decreased fat androstenone level.

Authors:  Zhihong Lin; Yanping Lou; John Peacock; E James Squires
Journal:  Mamm Genome       Date:  2005-05       Impact factor: 2.957

2.  Action of Halowax 1051 on Enzymes of Phase I (CYP1A1) and Phase II (SULT1A and COMT) Metabolism in the Pig Ovary.

Authors:  Justyna Barć; Anna Karpeta; Ewa Łucja Gregoraszczuk
Journal:  Int J Endocrinol       Date:  2013-04-04       Impact factor: 3.257

3.  Identification of the novel candidate genes and variants in boar liver tissues with divergent skatole levels using RNA deep sequencing.

Authors:  Asep Gunawan; Sudeep Sahadevan; Mehmet Ulas Cinar; Christiane Neuhoff; Christine Große-Brinkhaus; Luc Frieden; Dawit Tesfaye; Ernst Tholen; Christian Looft; Dessie Salilew Wondim; Michael Hölker; Karl Schellander; Muhammad Jasim Uddin
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

4.  Differential expression and co-expression gene networks reveal candidate biomarkers of boar taint in non-castrated pigs.

Authors:  Markus Drag; Ruta Skinkyté-Juskiené; Duy N Do; Lisette J A Kogelman; Haja N Kadarmideen
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

5.  Sex and site differences in urinary excretion of conjugated pyrene metabolites in the West African Shorthorn cattle.

Authors:  Nesta Bortey-Sam; Yoshinori Ikenaka; Osei Akoto; Shouta M M Nakayama; Jemima T Marfo; Aksorn Saengtienchai; Hazuki Mizukawa; Mayumi Ishizuka
Journal:  J Vet Med Sci       Date:  2017-12-27       Impact factor: 1.267

6.  Gene expression profiles in liver of pigs with extreme high and low levels of androstenone.

Authors:  Maren Moe; Sigbjørn Lien; Christian Bendixen; Jakob Hedegaard; Henrik Hornshøj; Ingunn Berget; Theo H E Meuwissen; Eli Grindflek
Journal:  BMC Vet Res       Date:  2008-08-06       Impact factor: 2.741

7.  Differential Gene Expression across Breed and Sex in Commercial Pigs Administered Fenbendazole and Flunixin Meglumine.

Authors:  Jeremy T Howard; Audrey T O'Nan; Christian Maltecca; Ronald E Baynes; Melissa S Ashwell
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.